The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and ...

As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common ...

Although semaglutide (Ozempic, Wegovy) and other GLP-1 drugs have ... European regulators announced that a safety panel found no link between GLP-1 drugs and thyroid cancer. Nevertheless, Pearce ...

A new study from researchers at the University of Queensland has found weight loss medications like Ozempic ... not due to suicide. Dr Siskind said there was a shared genetic link between sugar ...

Soon after, “no food sounded appetizing,” she added ... the estimated 15 million Americans who have taken Rybelsus, Ozempic, Wegovy, or another glucagon-like peptide-1 receptor agonist ...

SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy. These brand-name drugs were in short supply when they first came out, so the FDA ...

In a statement, Novo Nordisk said that patient safety is a priority while maintaining the Ozempic and Wegovy are secure ... be needed to further prove a link between the ingredient and the disease.

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...